DrugPatentWatch Database Preview
Clarus Company Profile
What is the competitive landscape for CLARUS, and when can generic versions of CLARUS drugs launch?
CLARUS has one approved drug.
There are three US patents protecting CLARUS drugs.
There are twenty-four patent family members on CLARUS drugs in nine countries.
Summary for Clarus
| International Patents: | 24 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Clarus
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clarus | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-001 | Mar 27, 2019 | RX | Yes | No | 8,241,664 | Start Trial | Y | Start Trial | |||
| Clarus | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-002 | Mar 27, 2019 | RX | Yes | No | 8,492,369 | Start Trial | Y | Start Trial | |||
| Clarus | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-001 | Mar 27, 2019 | RX | Yes | No | 8,492,369 | Start Trial | Y | Start Trial | |||
| Clarus | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-003 | Mar 27, 2019 | RX | Yes | Yes | 8,492,369 | Start Trial | Y | Start Trial | |||
| Clarus | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-002 | Mar 27, 2019 | RX | Yes | No | 8,778,916 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Clarus Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20130124414 | Start Trial |
| Japan | 5887044 | Start Trial |
| Russian Federation | 2623206 | Start Trial |
| Brazil | PI0607549 | Start Trial |
| Russian Federation | 2011119796 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
